This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Smith-Bindman and colleagues¹ report the results of a meta-analysis evaluating the role of endovaginal ultrasound (EVUS) in excluding endometrial cancer and other endometrial abnormalities. The other endometrial abnormalities include endometrial polyps and submucous leiomyomata, both common causes of postmenopausal bleeding. We agree that using an endometrial thickness threshold of 5 mm results in a high sensitivity and specificity for endometrial cancer. We believe that using EVUS alone is not adequate to exclude benign causes of postmenopausal bleeding and routinely perform hysterosonography in these patients.²

In a recently completed multicenter trial, we evaluated 124 patients who presented with postmenopausal bleeding. Each patient underwent endometrial biopsy, EVUS, and hysterosonography; 106 patients had the definitive diagnosis established with dilation and curettage (D&C), hysteroscopy, or hysterectomy. The remaining patients who had negative findings had 6-month follow-up with absence of disease and cessation of symptoms. Sixty percent of the patients were . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
Rebecca Smith-Bindman, Karla Kerlikowske, Vickie A. Feldstein, Leslee Subak, Juergen Scheidler, Mark Segal, Richard Brand, and Deborah Grady
JAMA. 1998;280(17):1510-1517.
ABSTRACT | FULL TEXT